Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, Castelli F, Gkrania-Klotsas E, Weld L, Lopez-Velez R, de Vries P, von Sonnenburg F, Loutan L, Parola P.

    Travel and migration associated infectious diseases morbidity in Europe, 2008.

    BMC INFECTIOUS DISEASES . 10: 330-330. Nº de citas: 104

    [doi:10.1186/1471-2334-10-330]

  • Reekie J, Kosa C, Engsig F, Monforte Ad, Wiercinska-Drapalo A, Domingo P, Antunes F, Clumeck N, Kirk O, Lundgren JD, Mocroft A.

    Relationship Between Current Level of Immunodeficiency and Non-Acquired Immunodeficiency Syndrome-Defining Malignancies

    CANCER . 116(22): 5306-5315. Nº de citas: 106

    [doi:10.1002/cncr.25311]

  • Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG, DAD study group.

    Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION . 17(5): 491-501. Nº de citas: 262

    [doi:10.1097/HJR.0b013e328336a150]

  • Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, Gatell J, Rakhmanova A, Johnson M, Kirk O, Lundgren J.

    Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 55(2): 262-270. Nº de citas: 194

    [doi:10.1097/QAI.0b013e3181e9be6b]

  • Fortun J, Martin-Davila P, Pascual J, Cervera C, Moreno A, Gavalda J, Aguado JM, Pereira P, Gurguí M, Carratala J, Fogueda M, Montejo M, Blasco F, Bou G, Torre-Cisneros J.

    Immunosuppressive therapy and infection after kidney transplantation

    TRANSPLANT INFECTIOUS DISEASE . 12(5): 397-405. Nº de citas: 44

    [doi:10.1111/j.1399-3062.2010.00526.x]

  • Pérez Molina JA, Rillo MM, Suárez-Lozano I, Casado Osorio JL, Cobo RT, González PR, Clotet EP, Jerez AH, Pedrol PD, Royuela A, Díaz EB, Esteban H, González-García J.

    Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study

    CURRENT HIV RESEARCH . 8(7): 521-530. Nº de citas: 18

  • Blanco JR, Caro AM, Pérez-Cachafeiro S, Gutiérrez F, Iribarren JA, González-García J, Ferrando-Martínez S, Navarro G, Moreno S.

    HIV Infection and Aging

    AIDS REVIEWS . 12(4): 218-230. Nº de citas: 42

  • Diaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

    Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain

    BMC INFECTIOUS DISEASES . 10: 267-267. Nº de citas: 14

    [doi:10.1186/1471-2334-10-267]

  • Zamarrón Fuertes P, Pérez-Ayala A, Pérez Molina JA, Norman FF, Monge-Maíllo B, Navarro M, López-Vélez R.

    Clinical and epidemiological characteristics of imported infectious diseases in Spanish travelers.

    JOURNAL OF TRAVEL MEDICINE . 17(5): 303-309. Nº de citas: 33

    [doi:10.1111/j.1708-8305.2010.00433.x]

  • Tang TH, López-Vélez R, Lanza M, Shelley AJ, Rubio JM, Luz SL.

    Nested PCR to detect and distinguish the sympatric filarial species Onchocerca volvulus, Mansonella ozzardi and Mansonella perstans in the Amazon Region.

    MEMORIAS DO INSTITUTO OSWALDO CRUZ . 105(6): 823-828. Nº de citas: 45

    [doi:10.1590/S0074-02762010000600016]

  • Pérez M, de Vinuesa AG, Sanchez-Duffhues G, Marquez N, Bellido ML, Muñoz-Fernandez MA, Moreno S, Castor TP, Calzado MA, Muñoz E.

    Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency

    CURRENT HIV RESEARCH . 8(6): 418-429. Nº de citas: 90

    [doi:10.2174/157016210793499312]

  • Pérez-Molina JA, Serrano O, Milinkovic A, Domingo P, Currán A, Knobel H, Gaspar G, Rodrigo A, Jiménez-Expósito MJ, Hernández-Novoa B, Moreno S, The NUCREST Study.

    Comparison of Antiviral Activity of Regimens Containing Nucleos(t)ide (NUC) Pairs in HIV-Infected Patients Initiating REScue Therapy (The NUCREST Study)

    HIV CLINICAL TRIALS . 11(5): 294-302. Nº de citas: 1

    [doi:10.1310/hct1105-294]

  • Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van Lunzen J, Chiesi A, Pradier C, Machala L, Lundgren JD.

    History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change*

    HIV MEDICINE . 11(7): 469-478. Nº de citas: 27

    [doi:10.1111/j.1468-1293.2009.00816.x]

  • Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN.

    Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per mu L in Europe and North America: a pooled cohort observational study

    Lancet (London, England) . 376(9738): 340-345. Nº de citas: 67

    [doi:10.1016/S0140-6736(10)60932-4]

  • Norman FF, Pérez de Ayala A, Pérez-Molina JA, Monge-Maillo B, Zamarrón P, López-Vélez R.

    Neglected tropical diseases outside the tropics.

    PLOS NEGLECTED TROPICAL DISEASES . 4(7): . Nº de citas: 37

    [doi:10.1371/journal.pntd.0000762]

  • Martínez E, Larrousse M, Llibre JM, Gutiérrez F, Saumoy M, Antela A, Knobel H, Murillas J, Berenguer J, Pich J, Pérez I, Gatell JM.

    Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.

    AIDS . 24(11): 1697-1707. Nº de citas: 145

    [doi:10.1097/QAD.0b013e32833a608a]

  • Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD.

    Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.

    AIDS . 24(11): 1667-1678.

    [doi:10.1097/QAD.0b013e328339fe53]

  • Barragán P, López-Velez R, Olmo M, Podzamczer D.

    Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.

    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE . 83(1): 10-12. Nº de citas: 11

    [doi:10.4269/ajtmh.2010.09-0594]